文献速递关节外科

口服氨甲环酸减少全膝关节置换术中的输血需求

Oral Tranexamic Acid Reduces Transfusions in Total Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2017-04-06

这项回顾性队列研究纳入接受初次单侧全膝关节置换术且未用氨甲环酸(n=866)、单剂口服氨甲环酸(n=157)或术前术后双剂口服氨甲环酸(n=1049)的患者,比较输血需求。结果显示,与未用口服氨甲环酸组相比,单剂组和双剂组的输血率均降低,且单剂与双剂组间无差异;术后血红蛋白下降幅度也降低。

要点

  • 输血率从无口服氨甲环酸组的15.4%降至单剂组的9.6%和双剂组的7%(均P<.001)。
  • 单剂与双剂口服氨甲环酸组的输血率无差异(P=.390)。
  • 术后血红蛋白下降从无口服氨甲环酸组的4.2 g/dL降至单剂组的3.5 g/dL和双剂组的3.4 g/dL(均P<.01)。

核心结论

  • 口服氨甲环酸可减少全膝关节置换术患者的输血需求,且给药更方便、成本效益优于其他给药方式。

研究设计与样本

  • 回顾性队列研究,纳入接受初次单侧全膝关节置换术的患者,分为未用氨甲环酸组(n=866)、单剂口服氨甲环酸组(n=157)和术前术后双剂口服氨甲环酸组(n=1049)。

主要发现

  • 输血率从无口服氨甲环酸组的15.4%降至单剂组的9.6%(P<.001)和双剂组的7%(P<.001)。
  • 单剂组与双剂组的输血率无差异(P=.390)。
  • 术后血红蛋白下降从无口服氨甲环酸组的4.2 g/dL降至单剂组的3.5 g/dL(P<.01)和双剂组的3.4 g/dL(P<.01)。
  • 单剂组与双剂组的术后血红蛋白下降无差异(P=.233)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tranexamic acid (TXA) reduces intraoperative blood loss and transfusions in patients undergoing total knee arthroplasty. Although numerous studies demonstrate the efficacy of intravenous and topical TXA in these patients, few demonstrate the effectiveness and appropriate dosing recommendations of oral formulations. METHODS: A retrospective cohort study was performed to evaluate differences in transfusion requirements in patients undergoing primary unilateral total knee arthroplasty with either no TXA (n = 866), a single-dose of oral TXA (n = 157), or both preoperative and postoperative oral TXA (n = 1049). Secondary outcomes included postoperative hemoglobin drop, total units transfused, length of stay, drain output, and cell salvage volume. RESULTS: Transfusion rates decreased from 15.4% in the no-oral tranexamic acid (OTA) group to 9.6% in the single-dose OTA group (P < .001) and 7% in the 2-dose group (P < .001), with no difference in transfusion rates between the single- and 2-dose groups (P = .390). In addition, postoperative hemoglobin drop was reduced from 4.2 g/dL in the no-OTA group to 3.5 g/dL in the single-dose group (P < .01) and to 3.4 g/dL in the 2-dose group (P < .01), without a difference between the single- and 2-dose groups (P = .233). CONCLUSION: OTA reduces transfusions, with greater ease of administration and improved cost-effectiveness relative to other forms of delivery.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Perreault RE, Fournier CA, Mattingly DA, et al. Oral Tranexamic Acid Reduces Transfusions in Total Knee Arthroplasty. J Arthroplasty. 2017. PMID: 28757131. doi:10.1016/j.arth.2017.03.063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。